Ancient wisdom meets modern oncology: can TCM body types forecast treatment side effects?
NCT ID NCT07741903
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This study is looking at whether a person's traditional Chinese medicine (TCM) constitution—a concept that categorizes individuals into different body types—can help predict who will experience diarrhea as a side effect of combined immunotherapy and targeted therapy for liver cancer. Researchers will follow 500 adults with hepatocellular carcinoma who are about to start this treatment, collecting detailed health information before they begin and tracking diarrhea over the following year. The goal is to build a risk prediction model that combines TCM and Western medical indicators, which could help doctors identify high-risk patients early and potentially reduce this distressing side effect.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- No drug or treatment is being tested. The study observes patients to build a risk prediction model based on traditional Chinese medicine (TCM) constitutional types.
- What this could lead to
- If successful, this could give doctors a simple tool to screen liver cancer patients before starting immunotherapy and targeted therapy, helping to identify those at higher risk of diarrhea and potentially prevent or better manage this side effect.
- What could go wrong
- This is an observational study, so it cannot prove that TCM types cause diarrhea. The model may not be accurate across different patient groups, and the study's findings depend on careful data collection and follow-up.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a new PET tracer light up hidden cancers?
- A new test could reveal how radiation affects the liver
- Can an immunotherapy drug keep liver cancer at bay after surgery?